Publications

Detailed Information

Diethylnitrosamine (DEN) induces irreversible hepatocellular carcinogenesis through overexpression of G(1)/S-phase regulatory proteins in rat

DC Field Value Language
dc.contributor.authorPark, Dae-Hun-
dc.contributor.authorShin, Jae Wook-
dc.contributor.authorPark, Seung-Kee-
dc.contributor.authorSeo, Jae-Nam-
dc.contributor.authorJang, Ja-June-
dc.contributor.authorLee, Min-Jae-
dc.contributor.authorLi, Lan-
dc.date.accessioned2012-05-30T02:37:57Z-
dc.date.available2012-05-30T02:37:57Z-
dc.date.issued2009-12-15-
dc.identifier.citationTOXICOLOGY LETTERS; Vol.191; 321-326ko_KR
dc.identifier.issn0378-4274-
dc.identifier.urihttps://hdl.handle.net/10371/76612-
dc.description.abstractHepatocellular carcinoma (HCC) is the fifth most frequent cause of cancer deaths in males and was the third most frequent cause of cancer deaths in 2007 throughout the world. The incidence rate is 2-3 times higher in developing countries than in developed countries. Animal models have enabled study of the mechanism of HCC and the development of possible strategies for treatment. Diethylnitrosamine (DEN) is a representative chemical carcinogen with the potential to cause tumors in various organs, including the liver, skin, gastrointestinal tract, and respiratory system Specifically in HCC, DEN is a complete carcinogen. Many lines of evidence have demonstrated a relationship between carcinogenesis and cell cycle regulation. In this study we found that cell cycle regulatory proteins were critically involved in cancer initiation and promotion by DEN. Cyclin D1. cyclin E, cdk4. and p21(CIP1/WAF1) I are factors whose expression levels may be useful as criteria for the classification of hepatic disease. In particular, cdk4 had a pivotal role in the transition to the neoplastic stage. In conclusion. we suggest that changes in the level of cdk4 may be useful as a biomarker for detection of HCC. (C) 2009 Elsevier Ireland Ltd. All rights reservedko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER IRELAND LTDko_KR
dc.subjectDiethylnitrosamine (DEN)ko_KR
dc.subjectIrreversible hepatocelluar carcinogenesisko_KR
dc.subjectG(1)/S phase regulatory proteinko_KR
dc.subjectcdk4ko_KR
dc.titleDiethylnitrosamine (DEN) induces irreversible hepatocellular carcinogenesis through overexpression of G(1)/S-phase regulatory proteins in ratko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor박대훈-
dc.contributor.AlternativeAuthor신재욱-
dc.contributor.AlternativeAuthor박승기-
dc.contributor.AlternativeAuthor서재남-
dc.contributor.AlternativeAuthor이란-
dc.contributor.AlternativeAuthor장자준-
dc.contributor.AlternativeAuthor이민재-
dc.identifier.doi10.1016/j.toxlet.2009.09.016-
dc.citation.journaltitleTOXICOLOGY LETTERS-
dc.description.citedreferenceChang JJ, 2008, MOL CELL TOXICOL, V4, P278-
dc.description.citedreferenceSell S, 2008, TUMOR BIOL, V29, P161, DOI 10.1159/000143402-
dc.description.citedreference*AM CANC SOC, 2007, GLOB CAN FACTS FIG 2-
dc.description.citedreferenceKim MR, 2005, EXP MOL MED, V37, P335-
dc.description.citedreferenceLI X, 2005, HEPATOB PANCREAT DIS, V4, P427-
dc.description.citedreferenceMasaki T, 2003, HEPATOLOGY, V37, P534, DOI 10.1053/jhep.2003.50112-
dc.description.citedreferencePascale RM, 2002, HEPATOLOGY, V35, P1341, DOI 10.1053/jhep.2002.33682-
dc.description.citedreferenceMasaki T, 2000, HEPATOLOGY, V32, P711, DOI 10.1053/jhep.2000.17705-
dc.description.citedreferencePerez-Roger I, 1999, EMBO J, V18, P5310-
dc.description.citedreferenceJohnson PJ, 1999, J GASTROEN HEPATOL, V14, pS32-
dc.description.citedreferenceVerna L, 1996, PHARMACOL THERAPEUT, V71, P57-
dc.description.citedreferenceSHERR CJ, 1994, CELL, V79, P551-
dc.description.citedreferenceHUNTER T, 1994, CELL, V79, P573-
dc.description.citedreferenceHUNTER T, 1991, CELL, V66, P1071-
dc.description.citedreferencePITOT HC, 1991, ENVIRON HEALTH PERSP, V93, P181-
dc.description.citedreferenceDRAGAN YP, 1991, PREV MED, V20, P15-
dc.description.citedreferenceXU YH, 1990, CANCER RES, V50, P472-
dc.description.citedreferenceBEER DG, 1987, ARCH TOXICOL S, V10, P68-
dc.description.citedreferenceRAO MS, 1986, CANCER RES, V46, P5287-
dc.description.citedreferenceFARBER E, 1984, CANCER RES, V44, P4217-
dc.description.citedreferenceWARD JM, 1981, VIRCHOWS ARCH A, V390, P339-
dc.description.citedreferenceCOHEN AH, 1976, J CLIN PATHOL, V65, P631-
dc.description.citedreferenceANDERSEN P, 1976, CLIN EXP IMMUNOL, V26, P57-
dc.description.tc5-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share